Greenphire Expands Agreement With Merck


Greenphire has announced an expansion of its agreement with Merck, known as MSD outside the US and Canada. This expanded agreement now includes the use of Greenphire's ClinCard with rideshare integration for participants across Merck's clinical development network.

Greenphire's ClinCard with rideshare integration is designed to help alleviate financial and logistical burdens on participants. ClinCard does not impose costs on sites and helps ensure patients are reimbursed in a timely manner so research sites can focus on conducting clinical trials.


Greenphire Expands Agreement with Merck to Help Reduce Financial and Travel Barriers for Clinical Trial Participants Worldwide. (2023, March 13). Cision PR Newswire.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Cat Hall endpoint Clinical
OM1 Sonja Wustrack
© 2023 MJH Life Sciences

All rights reserved.